March 14, 2025 04:47 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
In a setback for Donald Trump, US judge orders federal agencies to rehire fired workers: Report | 'We will thwart conspiracies hatched by Centre': Revanth Reddy on delimitation exercise | Chennai doctor, his wife along with two sons die by suicide due to huge debt: Cops | Amid language debate, Tamil Nadu drops rupee symbol in state budget | Scientist killed in assault by neighbour over parking argument in Mohali | British woman tourist raped in Delhi hotel by man she befriended on social media | Gold smuggling case: Court restrains media from publishing, telecasting defamatory statements against Ranya Rao | Trump warns Putin of 'devastating' financial impacts if Russia blocks Ukraine ceasefire | 'People are going to Russia right now as we speak: Donald Trump on Ukraine war ceasefire talks | Pakistani army claims to have freed all hostages in passenger train siege; 28 personnel killed
Johnson&Johnson Vaccine
Image Credit: Pixabay

US health regulator calls for pause in Johnson & Johnson vaccine use after cases of rare blood clots

| @indiablooms | Apr 14, 2021, at 04:27 am

Washington/IBNS: US's federal health officials on Tuesday called for a pause in the use of the Johnson & Johnson coronavirus vaccine after several cases of a rare and severe type of blood clot were reported among 6.8 million people who received the vaccine.

The Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) are now reviewing reports of six cases of a rare and severe type of blood clot among those who have received the jabs of Johnson & Johnson.

European health regulators are also investigating three additional cases of blood clots, Johnson & Johnson said adding that they are delaying the rollout of the vaccine there.

All six cases in the US occurred among women between the ages of 18 and 48, and symptoms occurred six to 13 days after vaccination, according to a statement issued by the FDA and CDC.

"Peter Marks, a top vaccine official at the FDA, said the clots are extremely similar to blood clots paired with low platelets that European regulators and scientists have determined are possibly triggered by an immune reaction to a separate vaccine developed by AstraZeneca and the University of Oxford," the Washington Post reported.

Earlier in March, several European countries like Denmark, Norway, Austria, Netherlands and Iceland had temporarily suspended the use of Oxford-AstraZeneca's Covid-19 vaccine over concerns about patients suffering from post-jab blood clots.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.